Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News aTyr Pharma Inc ATYR

Healthcare Biotechnology
aTyr Pharma, Inc., a clinical stage biotechnology company, engages in the discovery and development of product candidates that translate tRNA synthetase biology into new therapies for fibrosis and inflammation in the United States. Its lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase 3 clinical trial for the treatment of pulmonary sarcoidosis; and in... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:ATYR)

Levi & Korsinsky Invites Investors to SueWallSt After aTyr Pharma, Inc. Stock Collapse

ACCESS Newswire 40 minutes ago

ATYR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that aTyr Pharma, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

GlobeNewswire 3 hours ago

aTyr Pharma Inc. (ATYR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

PR Newswire 3 hours ago

ATYR 3-DAY DEADLINE ALERT: Hagens Berman Urges aTyr Pharma Investors to Act by Dec. 8 Deadline in Suit Over Trial Failure

PR Newswire 7 hours ago

Holzer & Holzer, LLC Reminds Investors of Upcoming December 8, 2025 Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Marex, Inc. (MRX), aTyr Pharma, Inc. (ATYR), WPP plc (WPP) , and Cepton, Inc. (CPTN)

GlobeNewswire 7 hours ago

SueWallSt Podcast Series Launches With Focus on aTyr Pharma, Inc. (ATYR) Fraud Allegations

ACCESS Newswire 7 hours ago

aTyr Pharma, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - ATYR

GlobeNewswire 7 hours ago

ATYR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Investors of aTyr Pharma, Inc. to Contact the Firm Today!

ACCESS Newswire 8 hours ago

Class Action Reminder from Pomerantz LLP for Investors of aTyr Pharma, Inc. - ATYR

ACCESS Newswire 8 hours ago
View More News ››

Opinion & Analysis (NDAQ:ATYR)

Kyorin's $175M Partnership Offers Good Life for aTyr Pharma in Japan

Streetwise Reports January 7, 2020

Expedition Mining (V.EXU) poised to target $28 billion endoscopy equipment market

Richard (Rick) Mills July 27, 2015
View More Opinion ››

Bullboard Posts (NDAQ:ATYR)

LIFE - Monday Rundown, Tuesday Expectations

<< View Post To Watch Video >>
HDavis - September 13, 2021

Life Technologies Announces Fourth Quarter and Fis

Life Technologies Announces Fourth Quarter and Fiscal 2012 Results Fourth quarter revenue increased 3% to $999 million, or 4.5...
bc4u - February 4, 2013

Where are you Posters?...

I have been patiently waiting to see some other investors post something of value on this board...obviously to no avail. So I guess that...
fedora - May 9, 2001

There's something here

For months you guys have been ignoring this stock. I t has a captive market, i.e. the invalid and the aging and it's margins are...
fedora - April 17, 2001
View more Bullboard ››

Electrum Discovery Corp.

Electrum Discovery Corp.

Electrum Discovery Corp. engages in the acquisition and exploration of mineral properties in the natural resource sector in ...
View More »